Racial differences in the prevalence of Parkinson's disease (PD) have been reported for decades. Many of the earliest reports were flawed because they were based on crude datasets, such as hospital databases, death certificates, door-to-door surveys and records of Medicare beneficiaries. These studies provided conflicting results and were found to have numerous biases. Publications with improved study designs in recent years have yielded higher quality findings that are worth reviewing. We reviewed studies published between 2005 and 2014 that analyzed the racial differences in Parkinson's disease diagnosis, treatment-including deep brain stimulation-and access to care. Literature searches were conducted in PubMed and EBSCO. These studies highlight advances in the field and explore differences in PD among ethnic and racial groups. Our literature review focused on prevalence, treatment and diagnosis discrepancies, and racial variations in the perceptions of aging. An appraisal of twelve reviewed studies determined a decrease in prevalence and incidence of PD in Americans of African descent compared to Caucasians. The studies also showed multiple health disparities, including lack of access to care, treatment, and inclusion in research. More studies are needed to address the causes and prevention of health disparities, as well as solutions, such as community outreach.
Introduction
Parkinson's disease (PD) is a neurodegenerative disorder that is diagnosed based on clinical features, including bradykinesia, resting tremor, rigidity, and postural stability.
These clinical findings are essential for physicians to make an accurate diagnosis, which subsequently will lead to improvement of clinical outcomes and quality of care. Studies have suggested there is a lower prevalence of PD among African-Americans. It is unclear if this is due to genetics, or inequalities among access to care, diagnosis, and treatment.
In 2004, McInerney-Leo et al. analyzed prevalence and incidence of PD among African-Americans compared to Caucasians [1] . There were six studies that analyzed the prevalence and incidence of PD through hospital records, physician registration and death certificates. The results were conflicting because of biased study designs, including low power, healthcare access, physician bias and ascertainment bias. The article recommended future studies conduct a long-term survey of the population to determine the incidence and phenotype of PD among Caucasians compared to African-Americans.
Understanding the epidemiological characters of PD among minorities will help to address the disparity in the care of this population. It will also ultimately provide a deeper understanding of the biological, environmental, and genetic mechanisms of the disease. Therefore, we undertook a literature review of racial disparities in PD focusing on articles published since 2004.
Methods
We performed a database search of articles published after 2004 that studied racial disparities in every facet of Parkinson's disease among patients of African ancestry compared to Caucasians. Topics included access to care, diagnosis, treatment, and inclusion in research. A search in PubMed and Medline of literature with the following terms: (racial disparities and Parkinson's disease) and (racial disparities and veterans affairs) resulted in ten studies; Two additional articles were obtained from references of the studies elicited from PubMed and Medline. We reviewed twelve studies published between 2005 and 2014, which are found in Table 1 . Many of the studies used the term white for Caucasian and black for African-American. A summation of the studies including the study design, study type, results, limitations and strengths are discussed below.
Results

Studies at Tertiary Movement Disorders Centers
In 2011, Hemming et al. assessed the racial and socioeconomic disparities (annual income and educational level) via cross-sectional analysis of patients seen at a tertiary Movement Disorders center at the University of Maryland. The authors evaluated the prevalence of PD among patients who self-identified as African-Americans compared to whites (93.4% white and 6.1% African-American).
The study revealed that African-Americans, at the time of diagnosis, had greater disability, disease severity, and were prescribed fewer anti-parkinson medications than Caucasians. Most notably, African-Americans had a two-fold increase in years between disease onset and diagnosis [2] . The limitations of this study included a small sample size (66 African-Americans) and referral bias given a select population referred to a tertiary center. Other confounding factors, such as socioeconomic status including income Understanding expectations about movement among the elderly through development of a scale.
Tilley et al. 2012
Clinical Trials A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy [15] Caucasian N = 1572 (90.2%) African-American N = 40 (2.3%) Hispanic/Latino N = 75 (4.3%) Asian N = 42 (2.4%) Other N = 13 (0.8%)
The Ancillary Trial lacked the overall number of participants that were needed for true analysis and was stopped early. and level of education. The authors stated racial disparities are multi-faceted, and recommend additional studies that assess the attitudes of patients and physicians regarding PD, PD referral and treatment.
Continued
Studies Using Databases
Willis et al. assessed racial differences in PD via a cross-sectional study, which also identified potential environmental factors. In this study, PD cases were identified from This was a well-designed study, which was well powered due to the large sample size.
It also analyzed the prevalence and incidence of PD, which included demographic as well as geographic factors. Willis et al. confirmed that the prevalence among AfricanAmericans were fifty percent lower than the prevalence among Caucasians. The incidence ratio among African-Americans as compared to Caucasians were higher than the prevalence ratio, suggesting African-Americans have a greater PD-related mortality than Caucasians. The study also reduced referral and selection bias because the cases were obtained from a database. Geographic and demographic variables were analyzed as well, which revealed a higher prevalence of PD in the Midwest and Northeast areas. viewed by trained nurses blinded to the study hypothesis to confirm the diagnosis of PD using ten indicator measures of PD care [6] . Out of five hundred seventy-seven cases with ICD-9 code 332.0, four hundred one PD cases were confirmed. Of those cases, twenty-seven were excluded due to lack of information about race or ethnicity. Results showed that physicians were more likely to confirm a diagnosis of PD among Non-Hispanic Whites than non-Whites. Physicians assessed depression equally among non-Hispanic whites and non-Whites, but the non-Hispanic whites were more likely to start treatment and receive follow-up. Patients who were offered treatment for depression and refused were included in the initial treatment group. Many providers did not document if they offered treatment for depression among the untreated group.
Access and Treatment Disparities
Dahodwala et al., Cheng African-Americans were found to have significantly fewer DBS procedures compared to Whites (unadjusted odds ratio, 0.13; 95% confidence interval, 0.11 -0.16; P < 0.001) [7] . After adjusting for comorbidities that may contraindicate DBS, African-Americans 
Perceptions of Normal Aging
An interesting confounding variable regarding PD epidemiology in different populations is variation in perceptions of normal aging. Dahodwala and colleagues were the first to examine this by comparing the stage of disease at which African-Americans and white PD patients were first diagnosed [8] . By comparing records from the Philadelphia Veterans Affairs Medical Center, they determined that African-American patients initially presented at more advanced stages of disease compared to their white counter- Discrepancies in perceptions of normal motor performance with aging was explored directly again by Dahodwala and colleagues [9] . They generated a novel assessment tool for testing participants' views on Expectations Regarding Movement (ERM) with questions tailored for parkinsonian symptoms. The investigators used this questionnaire to assess 210 senior center residents in Delaware County, Pennsylvania and demonstrated African-Americans held significantly lower expectations for maintenance of mobility compared to whites. However, there was no difference between the groups with respect to expectations of aging in general. Other participant characteristics that significantly improved ERM scores were higher education (more than high school) and better selfreported health (very good or excellent).
Another study investigated the issue of perceptional variation in PD with a twopronged approach in senior communities in Philadelphia [10] . The study first held focus groups in senior centers to obtain a qualitative understanding of differences in knowledge and perspectives on PD amongst whites, African-Americans and ChineseAmericans. In the quantitative arm of the study, Pan and colleagues constructed a questionnaire based on the findings from the 75 focus group participants. The questionnaire was administered to 154 individuals and revealed commonalities and differences between the three racial groups. Two common themes shared across groups were an overall lack of knowledge regarding the disease, and concern over losing independence as a consequence of developing PD. Distrust of the healthcare system and language barriers were identified as unique obstacles to treatment perceived by Africanand Chinese-Americans. Echoing previous studies, African-and Chinese-Americans were both more likely to view parkinsonian symptoms as part of normal aging compared to whites.
These three illustrative studies revealed substantial differences in both expectations for normal aging and perceived degree of disability from parkinsonian symptoms. The work highlights a likely contributing factor in the variance in PD prevalence amongst different racial and ethnic groups. These studies also point to the importance and need for outreach and education regarding PD in the senior population.
Discussion
Many of the studies revealed the incidence and prevalence of PD are higher among- Studies analyzing access and treatment disparities revealed a delay in diagnosis and treatment bias [8] . The studies were retrospective, which evaluated ICD-9 codes.
Therefore, they could not determine if the patient refused treatment or if the physician did not offer standard treatment making it difficult to determine the cause of these disparities. There were many hypotheses, which included underreporting of symptoms, mistrust of the medical field and lack of effective communication between the patient and physician [10] . African-Americans were also found to have greater disease severity and disability compared to whites likely as a result of delay in diagnosis and treatment [2] . The studies that revealed a treatment bias also did not address ways to prevent this challenging issue.
There were two studies analyzing the misperceptions of motor performance with ag- son's disease in a cohort study and they came to a similar conclusion. The racial differences in PD incidence were not elucidated by age, sex, income, insurance, geographic variation or healthcare utilization. They concluded that the racial disparities were more likely a result of discrimination or bias and a population-based approach will help determine the root cause of these differences. for an underserved population.
Conclusions
There were twelve studies analyzing the prevalence, incidence, management and treatment of Parkinson's disease among people of color compared with whites. Three studies analyzed the perception and knowledge of PD symptoms in different populations [8] [9] [10] . These studies emphasized the differences between racial and ethnic groups, but did not reveal the root of these perceptions.
The review articles revealed racial disparities in every facet of Parkinson's disease, from knowledge about the disease, to diagnosis, and finally treatment. Racial disparities also existed within the Veterans' Affairs health care system, which should provide an equal standard of care to all veterans. Unfortunately, the studies do not address the causes of these observations and further studies need to be conducted to determine racial. A community-based study has yet to be performed and may deepen our understanding of Parkinson's disease.
